Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Trophos

Trophos?uq=kzBhZRuG
1999 FOUNDED
M&A STATUS
11-20 EMPLOYEES
M&A LATEST DEAL TYPE
$509M LATEST DEAL AMOUNT
Description

Operator of a clinical stage pharmaceutical company engaged in development of drugs for the treatment of neurological and cardiac diseases. The company involves screening chemical collections of small molecules on models of sick neurons, using the class of neurons affected in each type of disease.

Website
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Parent Company
Primary Office
  • Parc scientifique de Luminy
  • Case 931
  • 13288 Marseille
  • France

+33 04 00 00 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Trophos’s full profile, request a free trial.

Trophos Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Merger/Acquisition 03-Mar-2015 $509M 000.00 00000 Completed Generating Revenue
7. Grant 11-Oct-2012 00.00 000.00 Completed Generating Revenue
6. Grant 26-Mar-2009 00.000 000.00 Completed Generating Revenue
5. Grant 23-Dec-2008 00.00 000.00 Completed Generating Revenue
4. Later Stage VC (Series C) 04-Sep-2007 000.00 000.00 Completed Generating Revenue
3. Grant 04-Sep-2007 000.00 000.00 Completed Generating Revenue
2. Early Stage VC 01-Apr-2003 $6.95M $22.8M Completed Startup
1. Early Stage VC $15.9M $15.9M Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Trophos Former Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
ACG Management Asset Manager Minority 000 0000 000000 0
APICAP Venture Capital Majority 000 0000 000000 0
Amundi Private Equity Funds PE/Buyout Minority 000 0000 000000 0
Arch Capital Group Corporation Minority 000 0000 000000 0
Association Française contre les Myopathies Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 11 investors. Get the full list »

Trophos Executive Team (9)

Name Title Board
Seat
Contact
Info
Marceline Clementine Chief Financial Officer
Patrick Berna Ph.D Chief Development Officer
Rebecca Pruss Ph.D Chief Scientific Officer
Carole Valenti Director, CMC
Valerie Cuvier Head, Clinical Operations

1 Former Executive

You’re viewing 5 of 9 executives. Get the full list »

Trophos Board Members (5)

Name Representing Role Since Contact
Info
BĂ©atrice Llirbat Ph.D Self Member of Supervisory Board 000 0000

4 Former Board Members

You’re viewing 1 of 5 board members. Get the full list »